Growth Metrics

Bruker (BRKRP) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Bruker - - 379.80 Mn -52.11%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -52.11%
Dec 31, 2025 8.42%
Sep 30, 2025 64.79%
Jun 30, 2025 93.12%
Mar 31, 2025 91.42%
Dec 31, 2024 -64.67%
Sep 30, 2024 56.39%
Jun 30, 2024 -4,995.77%
Mar 31, 2024 -181.15%
Dec 31, 2023 75.35%
Sep 30, 2023 -169.10%
Jun 30, 2023 -145.53%
Mar 31, 2023 -6.29%
Dec 31, 2022 -207.20%
Sep 30, 2022 -19.01%
Jun 30, 2022 179.97%
Mar 31, 2022 -324.17%
Dec 31, 2021 -68.75%
Sep 30, 2021 -0.41%
Jun 30, 2021 -372.85%
Mar 31, 2021 76.14%
Dec 31, 2020 26.53%
Sep 30, 2020 -282.54%
Jun 30, 2020 81.10%
Mar 31, 2020 -276.78%
Dec 31, 2019 74.92%
Sep 30, 2019 56.70%
Jun 30, 2019 -73.32%
Mar 31, 2019 -124.70%
Dec 31, 2018 -451.24%
Sep 30, 2018 -161.52%
Jun 30, 2018 9.07%
Mar 31, 2018 251.61%
Dec 31, 2017 210.42%
Sep 30, 2017 148.95%
Jun 30, 2017 -834.78%
Mar 31, 2017 -863.51%
Dec 31, 2016 7.57%
Sep 30, 2016 150.94%
Jun 30, 2016 143.67%
Mar 31, 2016 -29.82%
Dec 31, 2015 34.14%
Sep 30, 2015 29.49%
Jun 30, 2015 78.91%
Mar 31, 2015 27.85%
Dec 31, 2014 -688.10%
Sep 30, 2014 -171.28%
Jun 30, 2014 -320.79%
Mar 31, 2014 44.76%
Dec 31, 2013 69.45%
Sep 30, 2013 -27.45%
Jun 30, 2013 0.56%
Mar 31, 2013 56.00%
Dec 31, 2012 5.17%
Sep 30, 2012 -112.50%
Jun 30, 2012 20.09%
Mar 31, 2012 -221.78%
Dec 31, 2011 87.95%
Sep 30, 2011 26.53%
Jun 30, 2011 48.03%
Mar 31, 2011 -87.04%